1-11 of 11
ezh2 gene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frequent mutated B2M, EZH2 , IRF8 , and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

Ruben A.L. de Groen, Ronald van Eijk, Stefan Böhringer, Tom van Wezel, Richard Raghoo, Dina Ruano, Patty M. Jansen, Inge Briaire-de Bruijn, Fleur A. de Groot, Karin Kleiverda, Liane te Boome, Valeska Terpstra, Henriette Levenga, Alina Nicolae, Eduardus F.M. Posthuma, Isabelle Focke-Snieders, Lizan Hardi, Wietske C.E. den Hartog, Lara H. Bohmer, Pancras C.W. Hogendoorn, Anke van den Berg, Arjan Diepstra, Marcel Nijland, Pieternella J. Lugtenburg, Marie José Kersten, Steven T. Pals, Hendrik Veelken, Judith V.M.G. Bovée, Arjen H.G. Cleven, Joost S.P. Vermaat
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3760–3775.
https://doi.org/10.1182/bloodadvances.2021005215
Published: 2021
Includes: Supplemental data
Journal Articles

Treating lymphoma is now a bit EZ-er

Clinical Trials & Observations
Ryan D. Morin, Sarah E. Arthur, Sarit Assouline
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2256–2263.
https://doi.org/10.1182/bloodadvances.2020002773
Published: 2021
Journal Articles

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

Clinical Trials & Observations
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Jean-Christophe Ianotto, Brigitte Dupriez, Françoise Boyer, Maxime Renard, Olivier Mansier, Anne Murati, Jérôme Rey, Gabriel Etienne, Véronique Mansat-De Mas, Suzanne Tavitian, Olivier Nibourel, Stéphane Girault, Yannick Le Bris, François Girodon, Dana Ranta, Jean-Claude Chomel, Pascale Cony-Makhoul, Pierre Sujobert, Margot Robles, Raouf Ben Abdelali, Olivier Kosmider, Laurane Cottin, Lydia Roy, Ivan Sloma, Fabienne Vacheret, Mathieu Wemeau, Pascal Mossuz, Borhane Slama, Vincent Cussac, Guillaume Denis, Anouk Walter-Petrich, Barbara Burroni, Nathalie Jézéquel, Stéphane Giraudier, Eric Lippert, Gérard Socié, Jean-Jacques Kiladjian, Valérie Ugo
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1442–1451.
https://doi.org/10.1182/bloodadvances.2020003444
Published: 2021
Includes: Supplemental data
Journal Articles

Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma

Clinical Trials & Observations
Yana Pikman, Amy Saur Conway, Amanda L. Robichaud, Samuel Kitara, Alanna J. Church, Alyssa L. Kennedy, Lewis B. Silverman, Amy L. Billett, David M. Weinstock, Marian H. Harris, Kimberly Stegmaier
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1265–1269.
https://doi.org/10.1182/bloodadvances.2019001256
Published: 2020
Journal Articles

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Brian Reilly, Tiffany N. Tanaka, Dinh Diep, Huwate Yeerna, Pablo Tamayo, Kun Zhang, Rafael Bejar
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2845–2858.
https://doi.org/10.1182/bloodadvances.2019000192
Published: 2019
Includes: Supplemental data
Journal Articles

Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia

Elisavet Chartomatsidou, Stavroula Ntoufa, Konstantia Kotta, Alessandra Rovida, Maria Anna Akritidou, Daniela Belloni, Elisabetta Ferrero, Theoni Trangas, Niki Stavroyianni, Achilles Anagnostopoulos, Richard Rosenquist, Paolo Ghia, Nikos Papakonstantinou, Kostas Stamatopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1891–1896.
https://doi.org/10.1182/bloodadvances.2018030262
Published: 2019
Includes: Supplemental data
Journal Articles

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

Clinical Trials & Observations
Leylah M. Drusbosky, Neeraj Kumar Singh, Kimberly E. Hawkins, Cesia Salan, Madeleine Turcotte, Elizabeth A. Wise, Amy Meacham, Vindhya Vijay, Glenda G. Anderson, Charlie C. Kim, Saumya Radhakrishnan, Yashaswini Ullal, Anay Talawdekar, Huzaifa Sikora, Prashant Nair, Arati Khanna-Gupta, Taher Abbasi, Shireen Vali, Subharup Guha, Nosha Farhadfar, Hemant S. Murthy, Biljana N. Horn, Helen L. Leather, Paul Castillo, Caitlin Tucker, Christina Cline, Leslie Pettiford, Jatinder K. Lamba, Jan S. Moreb, Randy A. Brown, Maxim Norkin, John W. Hiemenz, Jack W. Hsu, William B. Slayton, John R. Wingard, Christopher R. Cogle
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1837–1847.
https://doi.org/10.1182/bloodadvances.2018028316
Published: 2019
Includes: Supplemental data
Journal Articles

Impact of somatic and germline mutations on the outcome of systemic mastocytosis

Clinical Trials & Observations
Javier I. Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, Jason D. Merker, Cristina Teodosio, Yanli Hou, Ana Henriques, Krishna M. Roskin, Laura Sanchez-Muñoz, Albert G. Tsai, Carolina Caldas, Almudena Matito, J. Ignacio Sánchez-Gallego, Andrea Mayado, Noelia Dasilva-Freire, Jason R. Gotlib, Luis Escribano, Alberto Orfao, Andrés C. García-Montero
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2814–2828.
https://doi.org/10.1182/bloodadvances.2018020628
Published: 2018
Includes: Supplemental data
Journal Articles

Targeted next-generation sequencing in blast phase myeloproliferative neoplasms

Clinical Trials & Observations
Terra L. Lasho, Mythri Mudireddy, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Natasha Szuber, Kebede H. Begna, Mrinal M. Patnaik, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi
Journal: Blood Advances
Blood Adv (2018) 2 (4): 370–380.
https://doi.org/10.1182/bloodadvances.2018015875
Published: 2018
Includes: Supplemental data
Journal Articles

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy

Clinical Trials & Observations
Jay Y. Spiegel, Caroline McNamara, James A. Kennedy, Tony Panzarella, Andrea Arruda, Tracy Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny Ho, Nancy Siddiq, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Karen Yee, Jamie Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1729–1738.
https://doi.org/10.1182/bloodadvances.2017009530
Published: 2017
Includes: Supplemental data
Journal Articles

Targeted deep sequencing in polycythemia vera and essential thrombocythemia

Clinical Trials & Observations
Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, Christy M. Finke, Giada Rotunno, Yoseph Elala, Annalisa Pacilli, Curtis A. Hanson, Alessandro Pancrazzi, Rhett P. Ketterling, Carmela Mannarelli, Daniela Barraco, Tiziana Fanelli, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi
Journal: Blood Advances
Blood Adv (2016) 1 (1): 21–30.
https://doi.org/10.1182/bloodadvances.2016000216
Published: 2016
Includes: Supplemental data